Novai

Novai is a biotechnology company commercialising DARC (Detection of Apoptosing Retinal Cells), a retinal biomarker platform combining a fluorescent biologic with an AI image analysis algorithm to detect single-cell apoptosis in the retina in vivo.

FDA and MHRA approved as an exploratory biomarker, DARC enables early detection of glaucoma and age-related macular degeneration.

Novai licenses the platform to pharmaceutical companies for patient stratification and treatment efficacy monitoring in ophthalmic and neurodegenerative clinical trials.